Brief: Inovio And Akeso Announce Clinical Collaboration To Advance Novel Combination Therapy For Glioblastoma (Gbm)
04/03/2026 13:06
March 4 (Reuters) - Akeso Inc 9926.HK: INOVIO AND AKESO ANNOUNCE CLINICAL COLLABORATION TO ADVANCE NOVEL COMBINATION THERAPY FOR GLIOBLASTOMA (GBM) INOVIO - DOSING IN COMBINATION THERAPY TRIAL EXPECTED TO BEGIN IN H2 2026 Source text: ID:nPn86DCrda Further company coverage: 9926.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inovio Pharmaceuticals
See all newsBrief: Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Q2 net loss narrows on warrant gain, lower costs
Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million